Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery

• Status: Completed
• Trial end date: 2007-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective of this study is to investigate the efficacy and safety of bromfenac ophthalmic solution for treatment of ocular inflammation and pain in subjects who undergo cataract extraction and intraocular lens implantation.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bausch & Lomb Incorporated
• Treatments: Anti-Inflammatory Agents, Non-Steroidal; Bromfenac; Ophthalmic Solutions; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Scheduled for unilateral cataract surgery with no other ophthalmic surgical procedures planned during cataract surgery

• Agree to return for all required visits

• Agree to avoid disallowed medications

Exclusion Criteria:

• Known hypersensitivity to bromfenac and salicylates